# A shared story of SCA3

**URL:** <https://forum.livingwithataxia.org/t/a-shared-story-of-sca3/8901>\
**Category:** General\
**Created:** [February 24, 2023, 1:57pm UTC](https://forum.livingwithataxia.org/t/a-shared-story-of-sca3/8901 "2023-02-24T13:57:45Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Beryl\_Park](https://yyz1.discourse-cdn.com/flex027/user_avatar/forum.livingwithataxia.org/beryl_park/32/5716_2.png) [@Beryl\_Park](https://forum.livingwithataxia.org/u/Beryl_Park)\
**Post date:** [February 24, 2023, 1:57pm UTC](https://forum.livingwithataxia.org/t/a-shared-story-of-sca3/8901/1 "2023-02-24T13:57:45Z")

</div>

Bill Moore & his daughter Jessica Oberlin, two members of NAF, recently shared their stories of living with SCA3 as part of a feature for the Critical Path to Therapeutics for the Ataxias (CPTA). The CPTA aims to optimize clinical trials for inherited Ataxias. Impact stories like theirs can help researchers & drug developers understand the realities of living with Ataxia. You can read it here: [CPTA — Impact Through Optimization of Clinical Trial Design | Critical Path Institute](https://c-path.org/impact_story/cpta-impact-through-optimization-of-clinical-trial-design/)